Related Experiment Videos
The search for the palmitoylethanolamide receptor
Jesse LoVerme1, Giovanna La Rana, Roberto Russo
1Center for Drug Discovery, University of California, Irvine, CA 92697-4260, USA.
Life Sciences
|June 21, 2005
Summary
Palmitoylethanolamide (PEA), an endogenous lipid, modulates pain and inflammation. Researchers identified peroxisome proliferator-activated receptor-alpha (PPAR-alpha) as the key receptor mediating PEA's anti-inflammatory effects.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Palmitoylethanolamide (PEA) is an endogenous lipid with known pain and inflammation modulating properties.
- The specific receptor responsible for PEA's anti-inflammatory actions remained unidentified for decades.
- Initial characterization of PEA's anti-inflammatory effects dates back nearly 50 years.
Observation:
- The ligand-activated transcription factor, peroxisome proliferator-activated receptor-alpha (PPAR-alpha), was investigated as a potential mediator.
- Recent research focused on identifying the elusive receptor for PEA.
Findings:
- Peroxisome proliferator-activated receptor-alpha (PPAR-alpha) has been identified as the receptor mediating the anti-inflammatory effects of Palmitoylethanolamide (PEA).
- This discovery clarifies the mechanism of action for PEA, a compound known for its therapeutic potential.
Implications:
- Understanding PEA's interaction with PPAR-alpha opens new avenues for developing targeted anti-inflammatory therapies.
- This finding enhances our knowledge of lipid signaling pathways in inflammation and pain management.
- Further research into PEA and PPAR-alpha may lead to novel treatments for inflammatory conditions.